RT @JIMD_Editors: Integration of genomics and metabolomics for prioritization of rare disease variants: a 2018 literature review Graham @Kl…
RT @JIMD_Editors: Integration of genomics and metabolomics for prioritization of rare disease variants: a 2018 literature review Graham @Kl…
Integration of genomics and metabolomics for prioritization of rare disease variants: a 2018 literature review Graham @Kluijt68 @UE66 et al https://t.co/oPMPQgIotk The authors consider the integration of untargeted metabolomics and WES/WGS for rapid diagn
RT @JIMD_Editors: Treatment in IMD may ameliorate symptoms or alter clinical course; effective treatment may therefore be dependent on prom…
RT @JIMD_Editors: Treatment in IMD may ameliorate symptoms or alter clinical course; effective treatment may therefore be dependent on prom…
RT @JIMD_Editors: Treatment in IMD may ameliorate symptoms or alter clinical course; effective treatment may therefore be dependent on prom…
Treatment in IMD may ameliorate symptoms or alter clinical course; effective treatment may therefore be dependent on prompt diagnosis. In this 2018 lit. review Graham et al look at combining untargeted #metabolomics with WES/WGS #openaccess https://t.co/oP
RT @rickdunnblade: Integration of genomics and metabolomics for prioritization of rare disease variants: a 2018 literature review. - PubMed…
RT @rickdunnblade: Integration of genomics and metabolomics for prioritization of rare disease variants: a 2018 literature review. - PubMed…
Integration of genomics and metabolomics for prioritization of rare disease variants: a 2018 literature review. - PubMed - NCBI https://t.co/OwfBLpuehZ